Inflammatory Bowel Disease Triggered by BNT162b2 mRNA Vaccination for SARS-CoV-2

Inflamm Bowel Dis. 2022 Jun 3;28(6):e75. doi: 10.1093/ibd/izab297.

Authors

Yosuke Shimodaira¹, Kenta Watanabe¹, So Takahashi¹, Shigeto Koizumi¹, Katsunori Iijima¹

Affiliation

¹ Department of Gastroenterology and Neurology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita City, Japan.

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Viral
BNT162 Vaccine* / adverse effects
COVID-19* / prevention & control
Humans
Inflammatory Bowel Diseases* / chemically induced
RNA, Messenger
Vaccination / adverse effects

Substances

Antibodies, Viral
RNA, Messenger
BNT162 Vaccine